Effects of canrenone in patients with metabolic syndrome

Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis

(2012) Li-jun Hu et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Effects of Aldosterone on Human Atherosclerosis: Plasma Aldosterone and Progression of Carotid Plaque

(2012) Omar de Rita et al.   CANADIAN JOURNAL OF CARDIOLOGY

The Ubiquitous Mineralocorticoid Receptor: Clinical Implications

(2012) Urseline A. Hawkins et al.   CURRENT HYPERTENSION REPORTS

Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways

(2012) Ana M. Briones et al.   HYPERTENSION

Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome

(2011) Roberto Fogari et al.   HYPERTENSION RESEARCH

Mineralocorticoid receptors in vascular function and disease

(2011) Amy McCurley et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Executive Summary: Standards of Medical Care in Diabetes--2011

(2010)   DIABETES CARE

Different Effects of Aliskiren and Losartan on Fibrinolysis and Insulin Sensitivity in Hypertensive Patients with Metabolic Syndrome

(2010) R. Fogari et al.   HORMONE AND METABOLIC RESEARCH

Effect of canrenone on left ventricular mechanics in patients with mild systolic heart failure and metabolic syndrome: The AREA-in-CHF study

(2010) G. de Simone et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Effect of a sequential training programme on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndrome

(2009) Arrigo F.G. Cicero et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION